Evidence map›Paper›PMID 42632107›Full record

ArticleJournal of the American Chemical Society2026

Bidirectional Allosteric Ligand Regulation in a Central Glycolytic Enzyme.

Belen Sundberg, Chenlin Lu, Malcolm L Wells, Kyle C Weber, Zhen Gong, Anum Glasgow

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Belen SundbergDepartment of Biochemistry and Molecular Biophysics, Columbia University, New York, New York10032, United States.
Chenlin LuDepartment of Biochemistry and Molecular Biophysics, Columbia University, New York, New York10032, United States.
Malcolm L WellsDepartment of Biochemistry and Molecular Biophysics, Columbia University, New York, New York10032, United States.
Kyle C WeberDepartment of Biochemistry and Molecular Biophysics, Columbia University, New York, New York10032, United States.
Zhen GongDepartment of Biochemistry and Molecular Biophysics, Columbia University, New York, New York10032, United States.
Anum GlasgowDepartment of Biochemistry and Molecular Biophysics, Columbia University, New York, New York10032, United States.ORCID 0000-0002-0938-881X

Funding

Mapping and rewiring protein allosteryR00GM135529 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GLASGOW, ANUM AZAM · 2022 to 2024
$747k
Mechanism-informed design of allosteric protein sensorsR35GM157185 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Anum Azam Glasgow · 2025 to 2026
$608k
American Cancer Society NANational Science Foundation Graduate Research Fellowship Program NANIGMS NIH HHS R00GM135529NIGMS NIH HHS R35GM157185
6 · The paper itself

Abstract

Allosteric regulation enables fine-tuned control of enzyme activity in response to cellular signals, yet its molecular basis often remains unclear. Phosphofructokinase-1 (PFK), the highly conserved, rate-limiting glycolytic enzyme, is a paradigm for Monod-Wyman-Changeux allosteric kinetics. However, X-ray crystal structures of bacterial PFK orthologs in distinct ligand-bound states do not show the consistent, concerted structural rearrangements expected for classical "relaxed" and "tense" states, revealing a decades-long disconnect between structure and function. We resolve this paradox by integrating biophysical and computational approaches to show that activator and inhibitor binding to the same allosteric pocket differentially reweight the conformational ensemble of Escherichia coli PFK. Activator binding enriches conformational substates that preorganize the catalytic site, whereas inhibitor binding upweights apo-like, catalytically incompetent substates. These findings establish an ensemble-based mechanism for PFK regulation and provide an energetic framework for understanding the expanded allosteric architecture of eukaryotic PFK orthologs.

Indexed as

Phosphofructokinase-1Allosteric RegulationCrystallography, X-RayEscherichia coliGlycolysisLigandsModels, MolecularLigandsPhosphofructokinase-1

Identifiers

PMID42632107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.